| [1] |
Hampel H,Mesulam MM,Cuello AC, et al. Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research[J]. J Prev Alzheimers Dis, 2019, 6(1): 2-15.
|
| [2] |
Cope TE,Rittman T,Borchert RJ, et al. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy[J]. Brain, 2018, 141(2):550-567.
|
| [3] |
Musi N,Valentine JM,Sickora KR, et al. Tau protein aggregation is associated with cellular senescence in the brain[J]. Aging Cell, 2018, 17(6): e12840.
|
| [4] |
Wei Y,Shin MR,Sesti F. Oxidation of KCNB1 channels in the human brain and in mouse model of Alzheimer's disease[J]. Cell Death Dis, 2018, 9(8): 820.
|
| [5] |
Gatt A,Ekonomou A,Somani A, et al. Importance of proactive treatment of depression in Lewy body dementias: The impact on hippocampal neurogenesis and cognition in a post-mortem study[J]. Dement Geriatr Cogn Disord, 2017, 44(5-6): 283-293.
|
| [6] |
Hu ZX,Song WN,Lu XD, et al. Peripheral T lymphocyte immunity and l-dopamine in patients with Parkinson's disease[J]. J Biol Regul Homeost Agents, 2018, 32(3): 687-691.
|
| [7] |
Pardiñas AF,Holmans P,Pocklington AJ, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection[J]. Nat Genet, 2018, 50(3): 381-389.
|
| [8] |
Shi Y,Lin S,Staats KA, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons[J]. Nat Med, 2018, 24(3): 313-325.
|
| [9] |
Sorrells SF,Paredes MF,Cebrian-Silla A, et al. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults[J]. Nature, 2018, 555(7696):377-381.
|
| [10] |
Boldrini M,Fulmore CA,Tartt AN, et al. Human hippocampal neurogenesis persists throughout aging[J]. Cell Stem Cell, 2018, 22(4): 589-599.
|
| [11] |
Nijboer CH,Kooijman E,van Velthoven CT, et al. Intranasal stem cell treatment as a novel therapy for subarachnoid hemorrhage[J]. Stem Cells Dev, 2018, 27(5): 313-325.
|
| [12] |
Kunath T,Natalwala A,Chan C, et al. Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?[J]. Eur J Neurosci, 2018, 49(4): 453-462.
|
| [13] |
da Silva JA,Tecuapetla F,Paixão V, et al. Dopamine neuron activity before action initiation gates and invigorates future movements[J]. Nature, 2018, 554(7691): 244-248.
|
| [14] |
Liu C,Kershberg L,Wang J, et al. Dopamine secretion is mediated by sparse active zone-like release sites[J]. Cell, 2018, 172(4): 706-718.
|
| [15] |
Konermann S,Lotfy P,Brideau NJ, et al. Transcriptome engineering with RNA-targeting Type VI-D CRISPR effectors[J]. Cell, 2018, 173(3): 665-676.e14.
|
| [16] |
Pignatelli M,Ryan TJ,Roy DS, et al. Engram cell excitability state determines the efficacy of memory retrieval[J]. Neuron, 2019, 101(2): 274-284.e5.
|
| [17] |
Bussian TJ,Aziz A,Meyer CF, et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline[J]. Nature, 2018, 562(7728): 578-582.
|
| [18] |
Bedrosian TA,Quayle C,Novaresi N, et al. Early life experience drives structural variation of neural genomes in mice[J]. Science, 2018, 359(6382): 1395-1399.
|
| [19] |
Levi AD,Anderson KD,Okonkwo DO, et al. Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury[J]. J Neurotrauma, 2018.
|
| [20] |
Guadalajara LH,León AM,Vaquero CJ, et al. Objective demonstration of improvement of neurogenic bowel dysfunction in a case of spinal cord injury following stem cell therapy[J]. J Surg Case Rep, 2018, 2018(11): rjy300.
|
| [21] |
Vaquero J,Zurita M,Rico MA, et al. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline[J]. Cytotherapy, 2018, 20(6):806-819.
|
| [22] |
Vaquero J,Zurita M,Rico MA, et al. Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyelia[J]. Cytotherapy, 2018, 20(6):796-805.
|
| [23] |
Vaquero J,Zurita M,Rico MA, et al. Intrathecal administration of autologous bone marrow stromal cells improves neuropathic pain in patients with spinal cord injury[J]. Neurosci Lett, 2018, 670: 14-18.
|
| [24] |
Santamaría AJ,Benavides FD,DiFede DL, et al. Clinical and neurophysiological changes after targeted intrathecal injections of bone marrow stem cells in a C3 tetraplegic subject[J]. J Neurotrauma, 2018, 36(3).
|
| [25] |
Moviglia GA,Brandolino MTM,Couto D, et al. Local immunomodulation and muscle progenitor cells induce recovery in atrophied muscles in spinal cord injury patients[J]. J Neurorestoratology, 2018, 6(1):136-145.
|
| [26] |
Al Kandari S,Prasad L,Al Kandari M, et al. Cell transplantation and clinical reality: Kuwait experience in persons with spinal cord injury[J]. Spinal Cord, 2018, 56(7): 674-679.
|
| [27] |
Liem NT,Chinh VD,Thinh NT, et al. Improved bowel function in patients with spina bifida after bone marrowderived mononuclear cell transplantation: A report of 2 cases[J]. Am J Case Rep, 2018, 19: 1010-1018.
|
| [28] |
Sung PH,Lin HS,Lin WC, et al. Intra-carotid arterial transfusion of autologous circulatory derived CD34+ cells for old ischemic stroke patients - a phase I clinical trial to evaluate safety and tolerability[J]. Am J Transl Res, 2018, 10(9):2975-2989.
|
| [29] |
Savitz SI,Yavagal D,Rappard G, et al. A phase 2 randomized, sham-controlled trial of internal carotid artery infusion of autologous bone marrow derived ALD-401 cells in patients with recent stable ischemic stroke (RECOVER-Stroke)[J]. Circulation, 2018, 139(2):192-205.
|
| [30] |
Laskowitz DT,Bennett ER,Durham RJ, et al. Allogeneic umbilical cord blood infusion for adults with ischemic stroke: Clinical outcomes from a phase I safety study[J]. Stem Cells Transl Med, 2018, 7(7): 521-529.
|
| [31] |
van Horne CG,Quintero JE,Slevin JT, et al. Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's diseaseduring deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome[J]. J Neurosurg, 2018, 129(6): 1550-1561.
|
| [32] |
Nguyen TL,Nguyen HP,Nguyen TK. The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy[J]. Health Qual Life Outcomes, 2018, 16(1):164.
|
| [33] |
Elena C,Ekaterina S,Marina K, et al. Monocyte-derived macrophages for treatment of cerebral palsy: A study of 57 cases. J Neurorestoratology, 2018, 6(1):41-47.
|
| [34] |
da Cruz L,Fynes K,Georgiadis O, et al. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration[J]. Nat Biotechnol, 2018, 36(4):328-337.
|
| [35] |
Mao G,Wang Y,Guo X, et al. Neurorestorative effect of olfactory ensheathing cells and Schwann cells by intranasal delivery for patients with ischemic stroke: Design of a multicenter randomized double-blinded placebo-controlled clinical study[J]. J Neurorestoratology, 2018, 6(1): 74-80.
|
| [36] |
Phan TG,Ma H,Lim R, et al. Phase 1 trial of amnion cell therapy for ischemic stroke[J]. Front Neurol, 2018, 9: 198.
|
| [37] |
Deng L,Peng Q,Wang H, et al. Intrathecal injection of allogenic bone marrow-derived mesenchymal stromal cells in treatment of patients with severe ischemic stroke: Study protocol for a randomized controlled observer-blinded trial[J]. Transl Stroke Res, 2018:1-8.
|
| [38] |
Osanai T,Houkin K,Uchiyama S, et al. Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design[J]. Int J Stroke, 2018, 13(4):444-448.
|
| [39] |
Garitaonandia I,Gonzalez R,Sherman GA, et al. Novel approach to stem cell therapy in Parkinson's disease[J]. Stem Cells Dev, 2018, 27(14):951-957.
|
| [40] |
Loring JF. Autologous induced pluripotent stem Cell-Derived neurons to treat parkinson's disease[J]. Stem Cells Dev, 2018, 27(14):958-959.
|
| [41] |
Cichoń N,Bijak M,Czarny P, et al. Increase in blood levels of growth factors involved in the neuroplasticity process by using an extremely low frequency electromagnetic field in post-stroke patients[J]. Front Aging Neurosci, 2018, 10: 294.
|
| [42] |
Angeli CA,Boakye M,Morton RA, et al. Recovery of over-ground walking after chronic motor complete spinal cord injury[J]. N Engl J Med, 2018, 379(13):1244-1250.
|
| [43] |
Gill ML,Grahn P,Calvert JS, et al. Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia[J]. Nat Med, 2018, 24(11): 1677-1682.
|
| [44] |
Herrity AN,Williams CS,Angeli C, et al. Lumbosacral spinal cord epidural stimulation improves voiding function after human spinal cord injury[J]. Sci Rep, 2018, 8(1):8688.
|
| [45] |
Terson de Paleville DGL,Harkema SJ,Angeli CA. Epidural stimulation with locomotor training improves body composition in individuals with cervical or upper thoracic motor complete spinal cord injury: A series of case studies[J]. J Spinal Cord Med, 2018, 42(1): 1-7.
|
| [46] |
Wagner FB,Mignardot JB,Le Goff-Mignardot CG, et al. Targeted neurotechnology restores walking in humans with spinal cord injury[J]. Nature, 2018, 563: 65-71.
|
| [47] |
Harkema SJ,Wang S,Angeli CA, et al. Normalization of blood pressure with spinal cord epidural stimulation after severe spinal cord injury[J]. Front Hum Neurosci, 2018, 12: 83.
|
| [48] |
Aslan SC,Legg Ditterline BE,Park MC, et al. Epidural spinal cord stimulation of lumbosacral networks modulates arterial blood pressure in individuals with spinal cord injury-induced cardiovascular deficits[J]. Front Physiol, 2018, 9:565.
|
| [49] |
PoianiR,Zaninotto AL,Carneiro AMC, et al. Photobiomodulation using low-level laser therapy (LLLT) for patients with chronic traumatic brain injury: A randomized controlled trial study protocol[J]. Trials, 2018, 19(1):17.
|
| [50] |
Santos JGRPD,Zaninotto ALC,Zângaro RA, et al. Effects of transcranial LED therapy on the cognitive rehabilitation for diffuse axonal injury due to severe acute traumatic brain injury:Study protocol for a randomized controlled trial[J]. Trials, 2018, 19(1):249.
|
| [51] |
da Silva T,da Silva FC,Gomes AO, et al. Effect of photobiomodulation treatment in the sublingual, radial artery region, and along the spinal column in individuals with multiple sclerosis: Protocol for a randomized, controlled, double-blind, clinical trial[J]. Medicine (Baltimore), 2018, 97(19):e0627.
|
| [52] |
Falci S,Indeck C,Barnkow D. Spinal cord injury below-level neuropathic pain relief with dorsal root entry zone microcoagulation performed caudal to level of complete spinal cord transection[J]. J Neurosurg Spine, 2018, 28(6):612-620.
|
| [53] |
Huang H,Al Zoubi Z. A brief introduction to the Special Issue on clinical treatment of spinal cord injury[J]. J Neurorestoratology, 2018, 6:134-135.
|
| [54] |
Ko CC,Tu TH,Wu JC, et al. Functional improvement in chronic human spinal cord injury: Four years after acidic fibroblast growth factor[J]. Sci Rep, 2018, 8(1):12691.
|
| [55] |
Derakhshanrad N,Saberi H,Yekaninejad MS, et al. Subcutaneous granulocyte colony-stimulating factor administration for subacute traumatic spinal cord injuries, report of neurological and functional outcomes:a double-blind randomized controlled clinical trial[J]. J Neurosurg Spine, 2018, 30(1):19-30.
|
| [56] |
Derakhshanrad N,Saberi H,Yekaninejad MS, et al. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries:a double-blind randomized controlled clinical trial[J]. J Neurosurg Spine, 2018, 29(1):97-107.
|
| [57] |
McDonald CM,Wong B,Flanigan KM, et al. Placebo-controlled phase 2 trial of drisapersen for duchenne muscular dystrophy[J]. Ann Clin Transl Neurol, 2018, 5(8):913-926.
|
| [58] |
Panza F,Seripa D,Lozupone M, et al. The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in People with inherited mutations that cause its early onset[J]. Expert Opin Biol Ther, 2018, 18(1):25-35.
|
| [59] |
Strauss KA,Carson VJ,Brigatti KW, et al. Preliminary safety and tolerability of a novel subcutaneous intrathecal catheter system for repeated outpatient dosing of nusinersen to children and adults with spinal muscular atrophy[J]. J Pediatr Orthop, 2018, 38(10):e610-e617.
|
| [60] |
Eckstein O,Mcatee CL,Greenberg J, et al. Rituximab therapy for patients with Langerhans cell histiocytosis-associated neurologic dysfunction[J]. Pediatr Hematol Oncol, 2018, 35(7-8):427-433.
|
| [61] |
Kucher K,Johns D,Maier D, et al. First-in-man intrathecal application of neurite growth-promoting Anti-Nogo-A antibodies in acute spinal cord injury[J]. Neurorehabil Neural Repair, 2018, 32(6-7):578-589.
|
| [62] |
Hubscher CH,Herrity AN,Williams CS, et al. Improvements in bladder, bowel and sexual outcomes following task-specific locomotor training in human spinal cord injury[J]. PLoS One, 2018, 13(1):0190998.
|
| [63] |
Sandroff BM,Motl RW,Bamman M, et al. Randomised controlled trial of exercise training for managing learning and memory impairment in persons with multiple sclerosis[J]. BMJ Open, 2018, 8(12):e023231.
|
| [64] |
Trento C,Bernardo ME,Nagler A, et al. Manufacturing mesenchymal stromal cells for the treatment of Graft-versus-Host disease: a survey among centers affiliated with the European society for blood and marrow transplantation[J]. Biol Blood Marrow Transplant, 2018, 24(11):2365-2370.
|
| [65] |
Qiang A, Juan X, Yanqiu Y, et al. Standards for the culture and quality control of umbilical cord mesenchymal stromal cells for neurorestorative clinical application (2017)[J]. J Neurorestoratology, 2017, 6:11-15.
|
| [66] |
Feng S,Xiao J,Han F, et al. Neurorestorative clinical application standards for the culture and quality control of neural progenitor/precursor cells (version 2017)[J]. J Neurorestoratology, 2018, 6:65-68.
|
| [67] |
Horwitz EM,Le Blanc K,Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2005, 7(5):393-395.
|
| [68] |
Dominici M,Le Blanc K,Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006, 8(4):315-317.
|
| [69] |
Galipeau J,Krampera M,Barrett J, et al. International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials[J]. Cytotherapy, 2016, 18(2):151-159.
|
| [70] |
Huang H,Young W,Chen L, et al. Clinical cell therapy guidelines for neurorestoration(IANR/CANR 2017)[J].Cell Transplant, 2018, 27(2):310-324.
|
| [71] |
Bikson M,Paneri B,Mourdoukoutas A, et al. Limited output transcranial electrical stimulation (LOTES-2017): Engineering principles, regulatory statutes, and industry standards for wellness, over-the-counter, or prescription devices with low risk[J]. Brain Stimul, 2018, 11(1):134-157.
|